All the Active Ingredient Drugs
Monoclonal Antibody. Daratumumab 20 mg/ml. Vial(Concentr. for sol. for IV infus.): 1 × 5, 20ml.
16 mg/kg body weight admin. as an IV infuse. accord. to the follow. dosing schedule: Wkly.: 1st – 8th week. Every 2 wks.: 9th -24th week. Every 4 wks.: 25th week onwards until dis. progres.
As monother. is indic. for the tmt. of adult pts. with relapsed and refract. multiple myeloma, whose prior ther. includ. a proteasome inhib. and an immunomodulat. agent and who have demonstrated dis.progres. on the last ther.